Bladder cancer survivorship -- Survivor burdens unmet needs -- CPEX testing in bladder cancer -- Management of low, intermediate and high risk bladder cancer -- Neoadjuvant chemotherapy in muscle invasive bladder cancer -- Multimodal therapy for muscle invasive bladder cancer -- None Muscle invasive bladder cancer- chemotherapy or resection -- Muscle invasive bladder cancer- open, laparoscopic or roboticG3 NMIBC- BCG versus cystectomy -- Role of immunotherapy in bladder cancer -- Robotic Surgery and bladder cancer -- Quality of life post Cystectomy -- The Neobladder and Quality of life -- Ileal conduit versus neobladder, which is better? -- Quality of life post NMIBC or BCG -- Rarc technical tips and tricks -- Robotic Surgery and resection -- Robotic radical cystectomy and PLND -- Robotic cystectomy and sentinal node mapping -- Robotic cystectomy and neobladder formation -- Robotic cystectomy and enhanced recovery -- Robotic radical cystectomy, pain and enhanced recovery -- Enhanced recovery and hypoalbumineamia -- The Robotic approach to redo surgery -- Robotic cystectomy and ureteric strictures -- BCG and cystectomy -- BCG and secondary malignancy. .

This book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors. Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients.